Euroimmun
Entry
2013
Hold
4yr
Exit
2017
Who owns Euroimmun?
Euroimmun was owned by Bioventure Management through Bioventure Club Deals (2011 vintage) from 2013 to 2017, exited via Trade Sale. Across its history, Euroimmun has been through 3 private equity ownership periods, detailed in the timeline below.
Buyer identity and MOIC available on Pro.
Hand-verified · updated 2026-08-10
Most recent investor
Bioventure ManagementBioventure Club Deals · 2011 · Life Sciences VC
3 ownership periods · full history below
Key facts
HQGermany
SectorMedTech
StatusAcquired
Key takeaways
- ·Fully exited in 2017.
- ·Average hold across 3 realized cycles: 6 years.
Ownership history
3 ownership periods · co-invest detected
Exited
Last exited in 2017 to .
Co-invest · 3 holders · 2006 · 2017
COI Partners Capital ManagementExited 2017
2010 · 2017(7yr) · COI Partners Deal-by-Deal · 2001 · Growth
Trade Sale · to
MOIC
–
Bioventure ManagementExited 2017
2013 · 2017(4yr) · Bioventure Club Deals · 2011 · Life Sciences VC
Trade Sale · to
MOIC
More from Bioventure Club Deals
Other portfolio companies in the same fund.
More PE-backed in MedTech
Comparable medtech deals from other GPs.
Optos
Exited 2015
Amadeus Capital Partners
UK
UKto
Axomove
Active
Go Capital
France· 2026
France· 2026Bioliberty
Active
Scottish National Investment BankUK· 2026
UK· 2026CertHub
Active
Cusp Capital Partners
Germany· 2026
Germany· 2026Clee Medical
Active
High-Tech Gruenderfonds (HTGF)
Switzerland· 2026
Switzerland· 2026CollimateHealth
Active
Caesar Ventures ManagementGermany· 2026
Germany· 2026Track Euroimmun
Save this record to your watchlist and pick up your research where you left off. No spam.
Get the full record on Euroimmun.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue